Renee L. Brooks

AIMS: The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) European Endocarditis (EURO-ENDO) registry aims to study the care and outcomes of patients diagnosed with infective endocarditis (IE) and compare findings with recommendations from the 2015 ESC Clinical Practice Guidelines for the management of IE and data from the 2001 Euro Heart Survey. METHODS AND RESULTS: Patients (n = 3116) aged over 18 years with a diagnosis of IE based on the ESC 2015 IE diagnostic criteria were prospectively identified between 1 January 2016 and 31 March 2018. Individual patient data were collected across 156 centres and 40 countries. The primary endpoint is all-cause mortality in hospital and at 1 year. Secondary endpoints are 1-year morbidity (all-cause hospitalization, any cardiac surgery, and IE relapse), the clinical, epidemiological, microbiological, and therapeutic characteristics of patients, the number and timing of non-invasive imaging techniques, and adherence to recommendations as stated in the 2015 ESC Clinical Practice Guidelines for the management of IE. CONCLUSION: EURO-ENDO is an international registry of care and outcomes of patients hospitalized with IE which will provide insights into the contemporary profile and management of patients with this challenging disease.

Purpose: Patient-initiated procedure cancellation on “short-notice” and failure to present (“no-show”) for previously scheduled GI endoscopic procedures is not an infrequent occurrence. One wonders whether asymptomatic persons scheduled for screening colonoscopy are more likely to cancel or “no-show” for their procedure than patients scheduled to have GI endoscopy for evaluation of “other” problems. This prospective study was designed to identify whether patients scheduled for screening colonoscopy are more likely to cancel or “no-show” than patients scheduled to have GI endoscopic procedures for “other” indications. Methods: All outpatients who either cancelled an endoscopic procedure on “short-notice” (within 48 hours prior to the anticipated procedure) or failed to present as scheduled (“no-show”), were identified in this prospective study. All patients had their procedures scheduled at either a local hospital or office-based ambulatory endoscopy unit. Rates of cancellation/“no-show” were then compared between patients who were scheduled to undergo screening colonoscopy and patients scheduled to undergo GI endoscopic procedures for “other” indications. Results: Over the study period (4/26/04 through 4/26/05), 6871 scheduled outpatients were eligible for inclusion in this prospective study. Of 6871 total outpatients, 322 were contacted after either cancellation or “no-show.” Group A included 2512 patients who were scheduled for screening colonoscopy (asymptomatic/average-risk), and of these 111 patients were contacted after cancellation or “no-showing,” yielding a rate of 4.4% (111/2512). Group B included 4359 patients scheduled during this period (for EGD or colonoscopy) for “all other” indications, and of these, 211 were contacted after cancellation or “no-showing”, yielding a rate of 4.8% (211/4359). The rate of cancellation/“no-show” was not significantly different between groups A and B (p = 0.442 = NS by Fischers exact test). Conclusions: The results from this prospective study suggest that asymptomatic/average-risk patients who are scheduled for screening colonoscopy are not more likely to cancel on “short notice” or “no-show” than are patients scheduled to undergo EGD or colonoscopy for “other” indications.

Yarze, Joseph C MD, FACP, FACG1; Brooks, Renee L RN, CGRN2; Schupp, Sandra L RN, CGRN2 Author Information